Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006390 |
---|---|
Receipt number | R000007297 |
Scientific Title | Phase III clinical trial in determining treatment strategy for patients with High grade T1 bladder cancer who have pT0 histology on the second TUR (JCOG1019, BC pT0 PhaseIII) |
Date of disclosure of the study information | 2011/09/22 |
Last modified on | 2021/01/06 13:37:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/09/22 12:02:10 | ||
2 | Update | 2012/05/25 13:56:59 | Institutions |
|
3 | Update | 2013/02/26 13:20:23 | Key inclusion criteria |
|
4 | Update | 2013/02/26 13:21:42 | Institutions |
|
5 | Update | 2013/08/01 18:09:48 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2013/08/01 18:10:24 | Key inclusion criteria |
|
7 | Update | 2013/08/01 18:14:34 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Address Address |
|
8 | Update | 2014/03/11 11:56:43 | TEL Institutions |
|
9 | Update | 2014/03/11 11:57:21 | Anticipated trial start date Last follow-up date |
|
10 | Update | 2016/08/09 19:27:01 | Division name Division name Address Address TEL Name of primary person or sponsor Organization Organization Category of Funding Organization Institutions |
|
11 | Update | 2016/08/09 19:27:54 | Last follow-up date |
|
12 | Update | 2021/01/06 13:37:03 | Recruitment status Date of IRB |